📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial. (2024)

First Author: Mayne KJ

Attributed to: Randomised trials in cardiovascular and metabolic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ndt/gfae203

PubMed Identifier: 39277784

Publication URI: http://europepmc.org/abstract/MED/39277784

Type: Journal Article/Review

Parent Publication: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

ISSN: 0931-0509